Patents by Inventor Robert M. Goodman
Robert M. Goodman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240139497Abstract: Various aspects of the present disclosure are directed toward implantable medical devices, systems, and methods for cardiac assistance.Type: ApplicationFiled: January 8, 2024Publication date: May 2, 2024Inventors: Scott M. Bryson, Dustin C. Burkart, Zachary A. Crannell, Joshua D. Cross, Robert M. Depue, James L. Goepfrich, Paul D. Goodman, Brandon C. Hedberg, Jason D. Hemmer, Jeffrey Kennington, Elton R. Migliati, Bryan Reep, Edward E. Shaw, James D. Silverman, Richard D. Strones
-
Patent number: 7115753Abstract: Disclosed are triaryl cationic compounds that exhibit broad spectrum antibiotic and antifungal activity, pharmaceutical compositions containing the compounds, and methods of treating bacterial and fungal infections using the compounds. The compounds were initially isolated by screening a 25,000-member bacterial artificial chromosome (BAC) library of environmental (eDNA) from soil. At least one clone produced a dark brown melanin-like compound that was found to have antibiotic activity. The compounds were isolated and synthesized de novo. From within the positive clone, a single open reading frame that shares extensive sequence similarity with members of the 4-hydroxyphenylpyruvate family of enzymes was found to be necessary and sufficient to confer the production of at least one of the subject compounds on E. coli.Type: GrantFiled: August 8, 2003Date of Patent: October 3, 2006Assignee: Wisconsin Alumni Research FoundationInventors: Jo E. Handelsman, Robert M. Goodman, Doreen E. Gillespie, Alan D. Bettermann, Jon C. Clardy, Sean F. Brady
-
Patent number: 7008767Abstract: The present invention provides methods and composition for accessing, in a generally unbaised manner, a diverse genetic pool for genes involved in biosynthetic pathways. The invention also provides compounds which can be identified by cloning biosynthetic pathways.Type: GrantFiled: June 8, 2001Date of Patent: March 7, 2006Assignee: Wisconsin Alumni Research FoundationInventors: Jo Handelsman, Robert M. Goodman, Michelle R. Rondon
-
Patent number: 6849397Abstract: Disclosed is a method to detect unlabeled nucleic acids (DNA and/or RNA) in a taxa, species, and organelle-specific fashion using surface plasmon resonance (SPR) imaging. Taxa-specific, species-specific, or organelle-specific nucleic acids are affixed to an SPR-suitable substrate. A nucleic acid sample to be analyzed is then contacted with the SPR-substrate and the substrate analyzed to determine the presence or absence of specific hybridization between the nucleic acids bound to the substrate and the nucleic acids contained in the sample. The method does not require that either the bound nucleic acids nor the sample nucleic acids be labeled. The method can be used to identify the source of nucleic acids, their sequence, as well as to identify organisms and place them within a given taxonomic hierarchy.Type: GrantFiled: November 29, 2001Date of Patent: February 1, 2005Assignee: Wisconsin Alumni Research FoundationInventors: Bryce P. Nelson, Mark R. Liles, Kendra Frederick, Robert M. Corn, Robert M. Goodman
-
Patent number: 6774283Abstract: Novel constructs are provided for expression of physiologically active mammalian proteins in plant cells, either in culture or under cultivation. The constructs provide a promoter functional in a plant host, a structural gene coding for mammalian protein and a terminator functional in a plant host. The construct is introduced into a plant cell to become integrated into the plant genome for expression in the plant cells or plants. The plant cells may be harvested and the mammalian protein isolated in physiologically active form.Type: GrantFiled: November 23, 1999Date of Patent: August 10, 2004Assignee: Calgene LLCInventors: Robert M. Goodman, Vic C. Knauf, Catherine M. Houck, Luca Comai
-
Publication number: 20040034088Abstract: Disclosed are triaryl cationic compounds that exhibit broad spectrum antibiotic and antifungal activity, pharmaceutical compositions containing the compounds, and methods of treating bacterial and fungal infections using the compounds. The compounds were initially isolated by screening a 25,000-member bacterial artificial chromosome (BAC) library of environmental (eDNA) from soil. At least one clone produced a dark brown melanin-like compound that was found to have antibiotic activity. The compounds were isolated and synthesized de novo. From within the positive clone, a single open reading frame that shares extensive sequence similarity with members of the 4-hydroxyphenylpyruvate family of enzymes was found to be necessary and sufficient to confer the production of at least one of the subject compounds on E. coli.Type: ApplicationFiled: August 8, 2003Publication date: February 19, 2004Inventors: Jo E. Handelsman, Robert M. Goodman, Doreen E. Gillespie, Alan D. Bettermann, Jon C. Clardy, Sean F. Brady
-
Publication number: 20030049639Abstract: Disclosed is a method to detect unlabeled nucleic acids (DNA and/or RNA) in a taxa, species, and organelle-specific fashion using surface plasmon resonance (SPR) imaging. Taxa-specific, species-specific, or organelle-specific nucleic acids are affixed to an SPR-suitable substrate. A nucleic acid sample to be analyzed is then contacted with the SPR-substrate and the substrate analyzed to determine the presence or absence of specific hybridization between the nucleic acids bound to the substrate and the nucleic acids contained in the sample. The method does not require that either the bound nucleic acids nor the sample nucleic acids be labeled. The method can be used to identify the source of nucleic acids, their sequence, as well as to identify organisms and place them within a given taxonomic hierarchy.Type: ApplicationFiled: November 29, 2001Publication date: March 13, 2003Inventors: Bryce P. Nelson, Mark R. Liles, Kendra Frederick, Robert M. Corn, Robert M. Goodman
-
Publication number: 20020045177Abstract: The present invention provides methods and composition for accessing, in a generally unbaised manner, a diverse genetic pool for genes involved in biosynthetic pathways. The invention also provides compounds which can be identified by cloning biosynthetic pathways.Type: ApplicationFiled: June 8, 2001Publication date: April 18, 2002Inventors: Jo Handelsman, Robert M. Goodman, Michelle R. Rondon
-
Publication number: 20010049830Abstract: Novel constructs are provided for expression of physiologically active mammalian proteins in plant cells, either in culture or under cultivation. The constructs provide a promoter functional in a plant host, a structural gene coding for mammalian protein and a terminator functional in a plant host. The construct is introduced into a plant cell to become integrated into the plant genome for expression in the plant cells or plants. The plant cells may be harvested and the mammalian protein isolated in physiologically active form.Type: ApplicationFiled: April 7, 1999Publication date: December 6, 2001Inventors: ROBERT M. GOODMAN, VIC C. KNAUF, CATHERINE HOUCK, LUCA COMAI
-
Publication number: 20010047029Abstract: Disclosed are triaryl cationic compounds that exhibit broad spectrum antibiotic and antifungal activity, pharmaceutical compositions containing the compounds, and methods of treating bacterial and fungal infections using the compounds. The compounds were initially isolated by screening a 25,000-member bacterial artificial chromosome (BAC) library of environmental (eDNA) from soil. At least one clone produced a dark brown melanin-like compound that was found to have antibiotic activity. The compounds were isolated and synthesized de novo. From within the positive clone, a single open reading frame that shares extensive sequence similarity with members of the 4-hydroxyphenylpyruvate family of enzymes was found to be necessary and sufficient to confer the production of at least one of the subject compounds on E. coli.Type: ApplicationFiled: February 23, 2001Publication date: November 29, 2001Inventors: Jo E. Handelsman, Robert M. Goodman, Doreen E. Gillespie, Alan D. Bettermann, Jon C. Clardy, Sean F. Brady
-
Patent number: 6261842Abstract: The present invention provides methods and compositions for accessing, in a generally unbaised manner, a diverse genetic pool for genes involved in biosynthetic pathways. The invention also provides compounds which can be identified by cloning biosynthetic pathways.Type: GrantFiled: November 13, 1997Date of Patent: July 17, 2001Assignee: Wisconsin Alumni Research FoundationInventors: Jo Handelsman, Robert M. Goodman, Michelle R. Rondon
-
Patent number: 6248567Abstract: Described herein is a method for selectively inhibiting the amplification of a specific DNA template during a polymerase chain reaction (PCR). In particular, the method is useful when the sequences of the desired and undesired DNA templates are similar. A set of universal primers binds to both the desired and undesired DNA templates during a PCR, resulting in the amplification of their DNA sequences. The method targets the undesired DNA template with three sets of oligonucleotide primers, one set of which is terminally modified to both prevent primer extension and increase the primer-template binding affinity. The result of these terminal modifications is the specific inhibition of the PCR amplification of the undesired DNA template, allowing the preferential amplification of the desired DNA templates.Type: GrantFiled: April 24, 2000Date of Patent: June 19, 2001Assignee: Wisconsin Alumni Research FoundationInventors: Mark R. Liles, Robert M. Goodman
-
Patent number: 6096547Abstract: Constructs are provided for expression of physiologically active mammalian proteins in plant cells, either in culture or under cultivation. The constructs provide a promoter functional in a plant host, a structural gene coding for mammalian protein and a terminator functional in a plant host. The construct is introduced into a plant cell to become integrated into the plant genome for expression in the plant cells or plants. The plant cells may be harvested and the mammalian protein isolated in physiologically active form.Type: GrantFiled: July 31, 1998Date of Patent: August 1, 2000Assignee: Calgene, LLCInventors: Robert M. Goodman, Vic C. Knauf, Catherine M. Houck, Luca Comai
-
Patent number: 5856154Abstract: The present invention provides chemically regulatable DNA sequences capable of regulating transcription of an associated DNA sequence in plants or plant tissues, chimeric constructions containing such sequences, vectors containing such sequences and chimeric constructions, and transgenic plants and plant tissues containing these chimeric constructions. In one aspect, the chemically regulatable DNA sequences of the invention are derived from the 5' region of genes encoding pathogenisis-related (PR) proteins. The present invention also provides anti-pathogenic sequences derived from novel cDNAs coding for PR proteins which can be genetically engineered and transformed into plants to confer enhanced resistance to disease.Type: GrantFiled: May 31, 1995Date of Patent: January 5, 1999Assignee: Novartis Finance CorporationInventors: John A. Ryals, Danny C. Alexander, Robert M. Goodman, Eric R. Ward
-
Patent number: 5777200Abstract: The present invention provides chemically regulatable DNA sequences capable of regulating transcription of an associated DNA sequence in plants or plant tissues, chimeric constructions containing such sequences, vectors containing such sequences and chimeric constructions, and transgenic plants and plant tissues containing these chimeric constructions. In one aspect, the chemically regulatable DNA sequences of the invention are derived from the 5' region of genes encoding pathogenisis-related (PR) proteins. The present invention also provides anti-pathogenic sequences derived from novel cDNAs coding for PR proteins which can be genetically engineered and transformed into plants to confer enhanced resistance to disease.Type: GrantFiled: May 31, 1995Date of Patent: July 7, 1998Assignee: Novartis Finance CorporationInventors: John A. Ryals, Danny C. Alexander, Robert M. Goodman, Jeffrey R. Stinson
-
Patent number: 5767369Abstract: The present invention provides chemically regulatable DNA sequences capable of regulating transcription of an associated DNA sequence in plants or plant tissues, chimeric constructions containing such sequences, vectors containing such sequences and chimeric constructions, and transgenic plants and plant tissues containing these chimeric constructions. In one aspect, the chemically regulatable DNA sequences of the invention are derived from the 5' region of genes encoding pathogenisis-related (PR) proteins. The present invention also provides anti-pathogenic sequences derived from novel cDNAs coding for PR proteins which can be genetically engineered and transformed into plants to confer enhanced resistance to disease.Type: GrantFiled: May 31, 1995Date of Patent: June 16, 1998Assignee: Novartis Finance CorporationInventors: John A. Ryals, Danny C. Alexander, Robert M. Goodman, Jeffrey R. Stinson
-
Patent number: 5700462Abstract: A novel strain of Bacillus cereus, designated MS1-9, has been isolated from the environment. The strain MS1-9, ATCC 55812, is one of a number of B. cereus strains which are useful as biocontrol agents to combat fungal damping off disease in field crop plants, and strain MS1-9 has exhibited good performance under high disease pressure among a large number of natural isolates in fostering the emergence and growth of alfalfa plants under normal field conditions in the upper midwestern U.S.Type: GrantFiled: November 12, 1996Date of Patent: December 23, 1997Assignee: Wisconsin Alumni Research FoundationInventors: Jo Handelsman, Eric V. Stabb, Lynn M. Jacobson, Robert M. Goodman, David W. Johnson, Kevin P. Smith
-
Patent number: 5650505Abstract: The present invention provides chemically regulatable DNA sequences capable of regulating transcription of an associated DNA sequence in plants or plant tissues, chimeric constructions containing such sequences, vectors containing such sequences and chimeric constructions, and transgenic plants and plant tissues containing these chimeric constructions. In one aspect, the chemically regulatable DNA sequences of the invention are derived from the 5' region of genes encoding pathogenisis-related (PR) proteins. The present invention also provides anti-pathogenic sequences derived from novel cDNAs coding for PR proteins which can be genetically engineered and transformed into plants to confer enhanced resistance to disease.Type: GrantFiled: May 24, 1995Date of Patent: July 22, 1997Assignee: Novartis CorporationInventors: John A. Ryals, Danny C. Alexander, James J. Beck, John H. Duesing, Robert M. Goodman, Leslie B. Friedrich, Christian Harms, Frederich Meins, Jr., Alice Montoya, deceased, Mary B. Moyer, Jean-Marc Neuhaus, George B. Payne, Christoph Sperisen, Jeffrey R. Stinson, Scott J. Uknes, Eric R. Ward, Shericca C. Williams
-
Patent number: 5629175Abstract: Novel constructs are provided for expression of physiologically active mammalian proteins in plant cells, either in culture or under cultivation. The constructs provide a promoter functional in a plant host, a structural gene coding for mammalian protein and a terminator functional in a plant host. The construct is introduced into a plant cell to become integrated into the plant genome for expression in the plant cells or plants. The plant cells may be harvested and the mammalian protein isolated in physiologically active form.Type: GrantFiled: June 5, 1995Date of Patent: May 13, 1997Assignee: Calgene, Inc.Inventors: Robert M. Goodman, Vic C. Knauf, Catherine M. Houck, Luca Comai
-
Patent number: 5614395Abstract: The present invention provides chemically regulatable DNA sequences capable of regulating transcription of an associated DNA sequence in plants or plant tissues, chimeric constructions containing such sequences, vectors containing such sequences and chimeric constructions, and transgenic plants and plant tissues containing these chimeric constructions. In one aspect, the chemically regulatable DNA sequences of the invention are derived from the 5' region of genes encoding pathogenisis-related (PR) proteins. The present invention also provides anti-pathogenic sequences derived from novel cDNAs coding for PR proteins which can be genetically engineered and transformed into plants to confer enhanced resistance to disease.Type: GrantFiled: January 13, 1994Date of Patent: March 25, 1997Assignee: Ciba-Geigy CorporationInventors: John A. Ryals, Danny C. Alexander, James J. Beck, John H. Duesing, Robert M. Goodman, Leslie B. Friedrich, Christian Harms, Frederich Meins, Jr., Alice Montoya, deceased, Mary B. Moyer, Jean-Marc Neuhaus, George B. Payne, Christoph Sperisen, Jeffrey R. Stinson, Scott J. Uknes, Eric R. Ward, Shericca C. Williams